Evidence map›Paper›PMID 41340068›Full record

ArticleDiagnostic and prognostic research2025

Quantifying the versatility of routinely measured prognostic factors.

Hamish Innes, Philip J Johnson

Abstract read
In one paragraph

Article in Diagnostic and prognostic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hamish InnesSchool of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK. Hamish.innes@gcu.ac.uk.
Philip J JohnsonDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.

Funding

MRF_ MRF-ELP-VAH-23-106
6 · The paper itself

Abstract

backgroundSome prognostic factors (PF) are "versatile" insofar as they predict diverse health outcomes (age is an exemplar par excellence). In this study, we sought to quantify the versatility of commonly measured PFs.

methodsParticipants from the UKB (UK biobank) study were followed from enrolment until the date of outcome or censoring. Over 800 incident adverse outcomes were considered, based on a unique 3-digit ICD code (A00, A01, A02, etc.). Twenty-four routine PFs-including renal, liver function and blood count biomarkers-featured in this analysis. Cox regression was used to determine the association between each PF with time to each outcome event. The number of statistically significant associations, direction of the association (positive/negative) and the median log hazard ratio (LHR) were determined for each PF. Data were visualised using Volcano plots.

resultsThe analysis included up to 502,408 UKB participants followed for 12.4 years. PFs with the greatest number of statistically significant associations were age (563/836; median LHR: 0.47), waist-hip ratio (530/836; LHR: 0.37) and hand-grip strength (416/836; LHR: 0.27). Conversely, PFs with the lowest number of significant associations were diastolic blood pressure (138/835; LHR: 0.11) and total protein (138/835; LHR: 0.11). Positive correlation was observed between the number of events a PF was associated with and the average effect size for those associations.

conclusionA wide spectrum exists between the most and least versatile PFs. In addition to age, waist-hip ratio and handgrip strength exhibit high versatility. Understanding PF versatility has implications for optimising the development/performance of prognostic models.

Indexed as

AlgorithmClinical prediction modelsPersonalised medicinePredictionPrognosisPrognostic factors

Identifiers

PMID41340068
PMCPMC12676796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.